Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Emopag, a new drug, preventively administered in doses of 10 and 30 mg/kg/day over 4 days produced a pronounced neuroprotective effect in the model of brain ischemia caused by gravitational overload and reduced animal mortality from 17 to 0%. The preparation more effectively corrected neurological deficit than the reference drugs Mexidol (in considerably larger doses of 30 and 90 mg/kg/day) and antihypoxic drug amtizol (30 mg/kg/day). Moreover, Emopag exhibited considerable antiamnestic activity comparable to that of Mexidol (in 3-fold higher doses); in a dose of 30 mg/kg/day Emopag was more effective than Mexidol and amtizol in the same dose. Thus, Emopag showed marked neuroprotective and antiamnestic effects in the model of gravitational overload in rats.

作者简介

V. Yasnetsov

State Research Center Institute of Biomedical Problems, Russian Academy of Sciences

编辑信件的主要联系方式.
Email: vicyas@yandex.ru
俄罗斯联邦, Moscow

T. Voronina

V. V. Zakusov Research Institute of Pharmacology

Email: vicyas@yandex.ru
俄罗斯联邦, Moscow

S. Skachilova

All-Russian Research Center for Safety of Bioactive Substances

Email: vicyas@yandex.ru
俄罗斯联邦, Staraya Kupavna

V. Yasnetsov

State Research Center Institute of Biomedical Problems, Russian Academy of Sciences

Email: vicyas@yandex.ru
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019
##common.cookie##